Imunon (IMNN) Earnings Date & Reports

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the bodyâ€™s natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies... Show more

Industry: #Medical Specialties

Get AI intraday signals

A.I. Advisor

published Earnings

IMNN is expected to report earnings to rise 19.29% to -33 cents per share on August 13

Q2'25

Est.

$-0.33

Q1'25

Beat

by $0.08

Q4'24

Beat

by $0.11

Q3'24

Beat

by $0.05

Q2'24

Beat

by $0.04

The last earnings report on May 12 showed earnings per share of -28 cents, beating the estimate of -35 cents. With 292.15K shares outstanding, the current market capitalization sits at 6.47M.

View a ticker or compare two or three

Compare

IMNN